Nucleix
9 known investors
Find your way into Nucleix
Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.
Founders & leadership

Investors · 9
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: RA Capital's portfolio page · funding news · sdbj.com · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · sdbj.com · Not right? Tell us
How we know: funding news · sdbj.com · Not right? Tell us
How we know: funding news · sdbj.com · Not right? Tell us
How we know: funding news · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$55M disclosed across 1 of 2 rounds · 2021–2022
- $55MraisedApr 2021 · 3 sources
RA Capital Management (lead), BlackRock, Lilly Asia Ventures, LYFE Capital, MILFAM
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Nucleix do?
- Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection. It serves the medical diagnostics and biotechnology market.
- Who are Nucleix's investors?
- Nucleix's investors include Gefen Capital, OrbiMed, RA Capital, Aurum Ventures MKI, BlackRock, Lilly Asia Ventures, LYFE Capital, Sands Capital Ventures.
- How much funding has Nucleix raised?
- Nucleix has disclosed $55M raised across 1 of its 2 known rounds.






